To find out more about children with Crohn’s Disease (CD) to help doctors improve the care of patients with this disease.
- Patient that has received at least 12 weeks of immunosuppressant therapy prior to registry entry.
- Parent/guardian hasa voluntarily signed and dated the ICF after the nature of the registry has been explained.
- Patients should not be enrolled into the Humira therapy group if they are currently being treated with any investigational agents or are using any investigational procedures.
- Patients should not be enrolled into the immunosuppressant group if they require ongoing treatment with approved biologics including Humira.
This is a 10 year study. Patients will be seen every 6 moths during their regularly scheduled visits. There are no blood collections, x rays, CT scans, or MRI’s required.